LexaGene to Present at the SNN Network Summer Virtual Event

by | Aug 16, 2021 | Investor Information

Home » Investor Information » LexaGene to Present at the SNN Network Summer Virtual Event

Dr. Jack Regan, our Founder and CEO, will present at this year’s SNN Network Summer Virtual Event on Thursday, August 19th. In addition to taking live questions from investors, Dr. Regan will be available for 1-on-1 meetings during the event.

“Since launching MiQLab™, we’ve experienced a tremendous amount of growth and positive momentum resulting from a number of scientific studies that have produced robust data validating our system’s efficacy,” said Dr. Jack Regan. “As we move ahead with our commercialization strategies, we continue to see great promise in the space of veterinary diagnostics, food safety, and biopharmaceutical manufacturing. We believe, MiQLab will change the way these industries conduct their business, for the better. I’m excited to speak to investors at this year’s SNN Network Virtual Event and share our vision for the future of molecular diagnostic testing.”

To register, visit SNN’s conference registration page.

Read more on Accesswire.

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>


LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility

Recently, we welcomed members of North Shore Technology Council and MassBio Leadership Teams into our facility at 500 Cummings Center for a full tour of our office space and laboratory spaces.

Upcoming Events

Access to Giving

July 13, 2021 - July 15, 2021
Access to Giving is a first-of-its-kind virtual investor conference where companies from microcap all the way up to megacap will have the opportunity to present their story and conduct 1x1 meetings with qualified investors, for charity.
1 2 3 7

Latest Resources

Listen to CEO and Founder, Dr. Jack Regan tell the LexaGene story to prospective investors, October 7, 2021.
1 2 3 5